Dong Sung Bio Pharm.Co.,Ltd. (KRX:002210)
973.00
-1,807.00 (-65.00%)
At close: Jun 24, 2025
KRX:002210 Revenue
In the year 2011, Dong Sung Bio Pharm.Co.,Ltd. had annual revenue of 78.44B KRW with 9.06% growth. Dong Sung Bio Pharm.Co.,Ltd. had revenue of 18.57B in the quarter ending June 30, 2013, a decrease of -0.97%.
Revenue
78.44B
Revenue Growth
+13.99%
P/S Ratio
0.30
Revenue / Employee
270.49M
Employees
290
Market Cap
23.24B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5,504.84B |
| Celltrion | 3,895.99B |
| ALTEOGEN | 202.18B |
| ABL Bio | 88.44B |
| SK Biopharmaceuticals | 675.41B |
| Yuhan | 2,136.67B |
| LigaChem Biosciences | 159.27B |
| Peptron | 6.19B |